60th Meeting on the Advisory Committee on Research on Women's Health (ACRWH)
Date and Time
– April 9, 2024, 4:35 PM EDTHybrid.
The 60th Meeting of the NIH Advisory Committee on Research on Women's Health (ACRWH) will provide a forum for ACRWH members to give advice and make recommendations on priority issues affecting women's health and sex differences research.
The NIH Revitalization Act of 1993 established the ACRWH, a Federal Advisory Committee Act (FACA) committee, to give advice and make recommendations on priority issues affecting women's health and sex differences research. ACRWH members are selected from among physicians, practitioners, scientists, and other health professionals who are not federal employees.
The ACRWH's responsibilities are to:
- Advise the ORWH director on appropriate NIH research activities in women's health
- Review the women's health research portfolio for NIH
- Survey goals for scientific career development
- Assess inclusion of women and minorities in NIH clinical research
9:30 a.m.–9:45 a.m. | Call to Order | Vivian Ota Wang, Ph.D., FACMG, CGC |
9:45 a.m.–10:30 a.m. | ORWH Director’s Report | Janine A. Clayton, M.D., FARVO |
10:30 a.m.–11:00 a.m.
| NIH Inclusion Update
| Dawn Corbett, M.P.H.
|
11:00 a.m.–11:05 a.m.
| Introduction of the NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives
| Tara A. Schwetz, Ph.D.
|
11:05 a.m.–11:20 a.m. | Open Discussion | Janine A. Clayton, M.D., FARVO |
11:20 a.m.–11:50 a.m.
| Enhancing Community Engagement at ORWH | Elizabeth Barr, Ph.D. |
11:50 a.m.–12:00 p.m. | Group Photo |
|
12:00 p.m.–12:45 p.m. | Lunch Break |
|
12:45 p.m.–1:45 p.m. | NIH Director's Report | Monica M. Bertagnolli, M.D. |
1:45 p.m.–2:25 p.m. | White House Women's Health Research Initiative Update | Carolyn Mazure, Ph.D.
|
2:25 p.m.–3:45 p.m. | Panel: Middle-Life Health of Women and Menopause
| Moderator: Chhanda Dutta, Ph.D.
|
Women and Alzheimer’s Disease Risk Begins in Midlife During the Menopausal Transition: Implications for Prevention and Treatment
| Roberta Diaz Brinton, Ph.D.
| |
Impact of the Midlife and Menopause on Bone Health: What We Know, What We Need to Learn
| Sherri-Ann Burnett-Bowie, M.D., M.P.H.
| |
Timing of Menopausal Hormone Therapy and Reduction of All-Cause Mortality and Cardiovascular Disease
| Howard Neil Hodis, M.D.
| |
3:45 p.m.–4:05 p.m. | Concept Clearance: NIH Office of Autoimmune Disease Research (OADR-ORWH) Notice of Special Interest (NOSI) | Victoria Shanmugam, MBBS, MRCP, FACR, CCD |
4:05 p.m.–4:30 p.m. | Open Discussion | Janine A. Clayton, M.D., FARVO |
4:30 p.m.–4:35 p.m. | Closing Statement | Janine A. Clayton, M.D., FARVO |
Sign language interpreting services are available upon request. Individuals who need interpreting services and/or other reasonable accommodations to participate in this event should contact Ashley Benitez at ashley.benitez@nih.gov. Requests should be made at least five business days prior to the event.